Streptonigrin Complex cytotoxic antibiotic obtained from Streptomyces flocculus or S. rufochronmogenus. It is used in advanced carcinoma and causes leukopenia.
Streptonigrin has been studied across 13 research domains including 🔬 Oncology, 🔬 Inflammation, 🧘 Stress & Anxiety, 🫁 Liver & Detox, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 26% of studies addressing this area.
The following compounds share molecular targets with Streptonigrin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Streptonigrin is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.